Cargando…
The therapeutic potential of escitalopram in the treatment of panic disorder
Panic disorder is a chronic and disabling condition that is often accompanied by other psychiatric and medical conditions. The serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been used effectively with panic disorder (PD) and conditions in which pa...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656325/ https://www.ncbi.nlm.nih.gov/pubmed/19300618 |
_version_ | 1782165496348540928 |
---|---|
author | Townsend, Mark H Conrad, Erich J |
author_facet | Townsend, Mark H Conrad, Erich J |
author_sort | Townsend, Mark H |
collection | PubMed |
description | Panic disorder is a chronic and disabling condition that is often accompanied by other psychiatric and medical conditions. The serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been used effectively with panic disorder (PD) and conditions in which panic attacks frequently occur. Escitalopram is the most selective SSRI and a variety of evidence suggests it is of great value in the treatment of panic disorder. In this paper, we review the theoretical and practical implications of its use. |
format | Text |
id | pubmed-2656325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26563252009-03-19 The therapeutic potential of escitalopram in the treatment of panic disorder Townsend, Mark H Conrad, Erich J Neuropsychiatr Dis Treat Expert Opinion Panic disorder is a chronic and disabling condition that is often accompanied by other psychiatric and medical conditions. The serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been used effectively with panic disorder (PD) and conditions in which panic attacks frequently occur. Escitalopram is the most selective SSRI and a variety of evidence suggests it is of great value in the treatment of panic disorder. In this paper, we review the theoretical and practical implications of its use. Dove Medical Press 2007-12 /pmc/articles/PMC2656325/ /pubmed/19300618 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Expert Opinion Townsend, Mark H Conrad, Erich J The therapeutic potential of escitalopram in the treatment of panic disorder |
title | The therapeutic potential of escitalopram in the treatment of panic disorder |
title_full | The therapeutic potential of escitalopram in the treatment of panic disorder |
title_fullStr | The therapeutic potential of escitalopram in the treatment of panic disorder |
title_full_unstemmed | The therapeutic potential of escitalopram in the treatment of panic disorder |
title_short | The therapeutic potential of escitalopram in the treatment of panic disorder |
title_sort | therapeutic potential of escitalopram in the treatment of panic disorder |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656325/ https://www.ncbi.nlm.nih.gov/pubmed/19300618 |
work_keys_str_mv | AT townsendmarkh thetherapeuticpotentialofescitalopraminthetreatmentofpanicdisorder AT conraderichj thetherapeuticpotentialofescitalopraminthetreatmentofpanicdisorder AT townsendmarkh therapeuticpotentialofescitalopraminthetreatmentofpanicdisorder AT conraderichj therapeuticpotentialofescitalopraminthetreatmentofpanicdisorder |